Background
Inhibition of pyruvate dehydrogenase kinase (PDK) by dichloroacetate (DCA) can shift tumor cell metabolism from anaerobic glycolysis to glucose oxidation, with activation of mitochondrial ...activity and chemotherapy-dependent apoptosis. In radiotherapy, DCA could thus potentially enhance the frequently moderate apoptotic response of cancer cells that results from their mitochondrial dysfunction. The aim of this study was to investigate tumor-specific radiosensitization by DCA in vitro and in a human tumor xenograft mouse model in vivo.
Materials and methods
The interaction of DCA with photon beam radiation was investigated in the human tumor cell lines WIDR (colorectal) and LN18 (glioma), as well as in the human normal tissue cell lines HUVEC (endothelial), MRC5 (lung fibroblasts) and TK6 (lymphoblastoid). Apoptosis induction in vitro was assessed by DAPI staining and sub-G1 flow cytometry; cell survival was quantified by clonogenic assay. The effect of DCA in vivo was investigated in WIDR xenograft tumors growing subcutaneously on BALB/c-nu/nu mice, with and without fractionated irradiation. Histological examination included TUNEL and Ki67 staining for apoptosis and proliferation, respectively, as well as pinomidazole labeling for hypoxia.
Results
DCA treatment led to decreased clonogenic survival and increased specific apoptosis rates in tumor cell lines (LN18, WIDR) but not in normal tissue cells (HUVEC, MRC5, TK6). However, this significant tumor-specific radiosensitization by DCA in vitro was not reflected by the situation in vivo: The growth suppression of WIDR xenograft tumors after irradiation was reduced upon additional DCA treatment (reflected by Ki67 expression levels), although early tumor cell apoptosis rates were significantly increased by DCA. This apparently paradoxical effect was accompanied by a marked DCA-dependent induction of hypoxia in tumor-tissue.
Conclusion
DCA induced tumor-specific radiosensitization in vitro but not in vivo. DCA also induced development of hypoxia in tumor tissue in vivo. Further investigations relating to the interplay between tumor cell metabolism and tumor microenvironment are necessary to explain the limited success of metabolic targeting in radiotherapy.
Safety considerations have always accompanied the development of new battery chemistries; this holds especially for the Li-ion battery with its highly reactive components. An overall assessment and ...decrease of risks of catastrophic failures such as during thermal runaway, requires an in-depth and quantitative understanding of the ongoing processes and their interaction. This can be provided by predictive mathematical models. Thus, we developed a thermal runaway model that focuses on rigorous modelling of thermodynamic properties and reactions of each component within a Li-ion battery. Moreover, the presented model considers vapour–liquid equilibria of a binary solvent mixture for the first time. Simulations show a fragile equilibrium between endothermic and exothermic reactions, such as LiPF6 and LEDC decomposition, in the early phases of self-heating. Further, an autocatalytic cycle involving the production of HF and the SEI component Li2CO3 could be revealed. Additionally, the unpredictability of the thermal runaway could be directly correlated to availability of LEDC or contaminants such as water. Also, solvent boiling can have a significant influence on the self-heating phase of a Li-ion battery, due to its endothermic nature. Further analysis revealed that the rising pressure, stemming from gassing reactions, can suppress solvent boiling until the thermal runaway occurs.
Display omitted
•First time consideration of phase equilibria in Li-ion battery thermal runaway.•Complex interaction of SEI degradation, reformation and solvent boiling revealed.•Fragile equilibrium of endo- and exothermic processes in self-heating phase.•Unpredictability of thermal runaway related to presence of LEDC or water.•Rising pressure from reaction gases can suppress solvent boiling.
PDF
